Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan versus rizatriptan patient preference study for acute migraine treatment
2006-002572-17Phase 4Completed
- Sponsor
- Istituto Lusofarmaco
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of frovatriptan and rizatriptan in migraine (2 arms), sponsored by Istituto Lusofarmaco. Primary endpoint: Patient preference for treatment medication. Started May 2007; status: completed.
02
Drugs
frovatriptanrizatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2006-002572-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002572-17.